Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 07:07 pm EDT
Mydecine Innovations Group Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was CAD 3.18 million compared to CAD 2.61 million a year ago. Basic loss per share from continuing operations was CAD 0.13.
For the six months, net loss was CAD 10.84 million compared to CAD 8.25 million a year ago. Basic loss per share from continuing operations was CAD 0.49.